Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03827460

Sex Differences in the Response to Abstinence From Alcohol.

In laboratory animals, repeated cycles of abstinence from and return to alcohol drinking can lead to changes in alcohol intake. In a study of the effect of abstinence on drinking in humans, the investigators found evidence that abstinence affects drinking differently in women compared to men. In the present study, the investigators propose to study how men and women respond to abstinence, and whether this information can be used to improve intervention and prevention strategies.

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

University Hospital

Indianapolis, Indiana, 46202, United States

Location status: Recruiting

Location contact

Martin H Plawecki, MD, PhD

PRINCIPAL_INVESTIGATOR

Melissa A Cyders, PhD

PRINCIPAL_INVESTIGATOR

Study Recruiter

CONTACT

[email protected]

317-948-6551

Wei Wu, PhD

SUB_INVESTIGATOR

About this study

Women and men differ in how quickly they progress from social to problematic alcohol drinking. In laboratory animals, short-term abstinence increases alcohol consumption, with repeated deprivations leading to disordered drinking. In a preliminary study, the investigators found that men and women differed in how their motivation to drink alcohol changed after a short period of abstinence. The investigators hypothesize that this difference may affect their transition to alcohol use disorders. The objectives of this application are to characterize the human post abstinence response, and use identical alcohol exposures to study the mechanisms underlying identified sex differences. In addition, the investigators will complete a 2 year prospective study of natural drinking patterns to assess how self-reported abstinence intervals influence drinking trajectories. The long-term goal of this project is to inform alcohol use disorder treatment and to design and test novel interventions using the laboratory model of post-abstinence response. There is a critical unfilled need to understand sex differences in disease progression, and this lab-based assessment coupled to longitudinal follow-up provides the rigorous experimental design to begin to meet that need. This project will increase scientific knowledge by advancing the translation between preclinical and clinical models, eventually informing sex-specific intervention and prevention strategies for problematic drinking and establishing a model to test those interventions..

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Moderate social drinkers
  • Able to understand/complete questionnaires and procedures in English
  • Body mass index (BMI) between 18.5 and 32 kg/m2
  • Have venous access sufficient to allow blood sampling

Exclusion criteria

  • Pregnant or breast-feeding women, or women who intend to become pregnant
  • Do not attest to using accepted forms of birth control for the infusion phase of the study
  • Current treatment for, or desire to be treated for, any substance use disorder or court ordered to not drink alcohol
  • History of significant adverse reaction to alcohol
  • Medical disorders or other conditions such as alcohol withdrawal seizures or delirium tremens that may influence study outcome or participant safety
  • Medications (past 30 days) that could influence data or participant safety (e.g. antidepressants, antipsychotics, benzodiazepines, etc.) as determined by investigators
  • DSM 5 Disorders (non AUD) or current/history of neurological disease of cerebral origin, or head injury with > 20 min loss of consciousness
  • Positive breath alcohol reading on arrival at any study visit
  • Actively suicidal (for example, any suicide attempts within the past year or any current suicidal intent, including a plan) or are at serious suicidal risk, by clinical judgment of the investigator
  • Any condition for which the principal investigators determine it is unsafe or not prudent to enroll

Treatment and study plan

Abstinence from alcohol

Behavioral

Participants will undergo a laboratory alcohol infusion session that terminates 2 weeks of monitored abstinence from alcohol

Usual drinking

Behavioral

Participants will undergo a laboratory alcohol infusion session during a period of usual drinking behavior

Intravenous Alcohol

Drug

During the laboratory alcohol infusion sessions, alcohol is infused through an indwelling catheter.

Other names: 6.0& (v/V) ethanol solution

Primary outcomes

  1. Sex differences in the effect of abstinence on alcohol self-administration.

    Time frame: 2 single day laboratory sessions, one following 2 weeks alcohol abstinence

    The effect of 2 weeks abstinence on intravenous alcohol intake will be compared in men and women.

  2. Sex differences in the effect of abstinence on sensitivity of the P3 response to alcohol.

    Time frame: 2 single day laboratory sessions, one following 2 weeks alcohol abstinence

    The effect of 2 weeks abstinence from alcohol on sensitivity of the neurophysiological P3 response to alcohol, assessed using a stop-signal response task, will be compared in women and men during an iv infusion clamp.

  3. Sex differences in the effect of abstinence on subjective responses to alcohol.

    Time frame: 2 single day laboratory sessions, one following 2 weeks alcohol abstinence

    The effect of 2 weeks abstinence from alcohol on subjective responses to alcohol in women and men will be assessed using a survey during an iv infusion clamp.

  4. The role of changes in alcohol elimination on sex differences in response to abstinence.

    Time frame: 2 single day laboratory sessions, one following 2 weeks alcohol abstinence

    The effect of 2 weeks abstinence from alcohol on alcohol elimination in men and women will be assessed using an iv alcohol infusion clamp.

Secondary outcomes

  1. Response to abstinence as a predictor of alcohol risk in women and men.

    Time frame: 2 years

    For both Arm 1 and Arm 2, daily alcohol consumption will be surveyed every 2 months for 2 years following the laboratory sessions. Self-imposed periods of abstinence will be assessed to determine if subsequent daily alcohol intake increases or decreases, and to determine if men and women differ in the effect of abstinence on drinking.

Study contacts

Contact information is provided by the study sponsor or research team.

Ann E Kosobud, Ph.D.

CONTACT

[email protected]

(317) 274-0087

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Registry information

Acronym: SPAR

Important dates

Study start
2019
Primary completion
2026
Study completion
2028
First posted
Feb 1, 2019
Registry last updated
May 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.